Immunosuppression for progressive membranous nephropathy: a UK randomised controlled trial

BACKGROUND: Membranous nephropathy leads to end-stage renal disease in more than 20% of patients. Although immunosuppressive therapy benefits some patients, trial evidence for the subset of patients with declining renal function is not available. We aimed to assess whether immunosuppression preserve...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Howman, Andrew, Chapman, Tracey L, Langdon, Maria M, Ferguson, Caroline, Adu, Dwomoa, Feehally, John, Gaskin, Gillian J, Jayne, David RW, O'Donoghue, Donal, Boulton-Jones, Michael, Mathieson, Peter W
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Lancet Publishing Group 2013
Konular:
Articles
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3590447/
https://ncbi.nlm.nih.gov/pubmed/23312808
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S0140-6736(12)61566-9
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller